Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids

Author:

Vatner Daniel F.,Majumdar Sachin K.,Kumashiro Naoki,Petersen Max C.,Rahimi Yasmeen,Gattu Arijeet K.,Bears Mitchell,Camporez João-Paulo G.,Cline Gary W.,Jurczak Michael J.,Samuel Varman T.,Shulman Gerald I.

Abstract

A central paradox in type 2 diabetes is the apparent selective nature of hepatic insulin resistance—wherein insulin fails to suppress hepatic glucose production yet continues to stimulate lipogenesis, resulting in hyperglycemia, hyperlipidemia, and hepatic steatosis. Although efforts to explain this have focused on finding a branch point in insulin signaling where hepatic glucose and lipid metabolism diverge, we hypothesized that hepatic triglyceride synthesis could be driven by substrate, independent of changes in hepatic insulin signaling. We tested this hypothesis in rats by infusing [U-13C] palmitate to measure rates of fatty acid esterification into hepatic triglyceride while varying plasma fatty acid and insulin concentrations independently. These experiments were performed in normal rats, high fat-fed insulin-resistant rats, and insulin receptor 2′-O-methoxyethyl chimeric antisense oligonucleotide-treated rats. Rates of fatty acid esterification into hepatic triglyceride were found to be dependent on plasma fatty acid infusion rates, independent of changes in plasma insulin concentrations and independent of hepatocellular insulin signaling. Taken together, these results obviate a paradox of selective insulin resistance, because the major source of hepatic lipid synthesis, esterification of preformed fatty acids, is primarily dependent on substrate delivery and largely independent of hepatic insulin action.

Funder

HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases

The American Diabetes Association Research Foundation

Novo Nordisk Foundation Center for Basic Metabolic Research

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Cited by 174 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. CDK6 inhibits de novo lipogenesis in white adipose tissues but not in the liver;Nature Communications;2024-02-05

2. Insulin Resistance in Type 2 Diabetes;Textbook of Diabetes;2024-01-12

3. Fatty Acid Esterification as a NASH Therapeutic Target;Cellular and Molecular Gastroenterology and Hepatology;2024

4. Nonalcoholic fatty liver disease and insulin resistance in children;Clinical and Experimental Pediatrics;2023-12-15

5. F6P/G6P-mediated ChREBP activation promotes the insulin resistance-driven hepatic lipid deposition in zebrafish;The Journal of Nutritional Biochemistry;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3